Portfolio Archive - Page 14 of 60 - Bryan, Garnier & Co

Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of Sword GRC to Riskonnect, a portfolio company of TA Associates

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Aelis Farma’s Euronext Paris EUR 25m Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to clinical-stage biologics company BiosanaPharma on its global strategic partnership with Alvotech

Bryan, Garnier & Co acts as Sole Financial Advisor to Padoa and its shareholders on the investment of Five Arrows Growth Capital

Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CyberCité, a SEO and SEA agency, on the sale of the Company to Isoskele, part of Groupe La Poste

Bryan, Garnier & Co acts as Sole Financial Advisor to MNH on the sale of AKLIA to Hoppen

Bryan, Garnier & Co is proud to act as Joint Bookrunner to Cell Impact on its SEK 349m Rights Issue

Bryan, Garnier & Co acts as Sole Financial Advisor to Wandercraft on its $45 million Fundraising

Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CMN on its partnership with MBO & Co

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Headwall Photonics on the sale of the company to Arsenal Capital Partners

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }